DOI:
10.1055/s-00033990
TH Open
LinksClose Window
References
Novo Nordisk.
FDA Approves NOVO NORDISK's NovoSeven® RT (Coagulation Factor VIIa [Recombinant] Room Temperature Stable) for Hemophilia Patients with Inhibitors.
Available at:
http://press.novonordisk-us.com/News-Releases?item=122388
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.